XML 45 R4.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Statements of Operations (USD $)
 6 Months Ended 12 Months Ended
Jun. 30, 2014
Dec. 31, 2013
Dec. 31, 2012
Income Statement [Abstract]      
Revenue         
Operating expenses:      
Research and development (839,959) (5,248,669) (667,474)
General and administrative (12,106,859) (1,525,257) (2,489,235)
Total operating expenses (12,946,818) (6,773,926) (3,156,709)
Loss from operations (12,946,818) (6,773,926) (3,156,709)
Other (expenses) income:      
Loss on change in fair value of derivative liabilities (7,954,970) (12,877,675) (3,688,353)
Interest income 1,411    12,753
Interest expense (435,611) (220,307) (27,721)
Total other (expenses) income (8,389,170) (13,097,982) (3,703,321)
Net loss $ (21,335,988) $ (19,871,908) $ (6,860,030)
Net loss per common share - basic and diluted $ (1.73) $ (8.18) $ (3.17)
Weighted average number of common shares outstanding - basic and diluted 12,332,331 2,429,267 2,166,498